Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium

Journal of Thoracic and Cardiovascular Surgery

Volumn 150, Issue 5, 2015, Pages 1268-1277

  Gaffey, Ann C ^a   Chen, Minna H ^b   Venkataraman, Chantel M ^a   Trubelja, Alen ^a   Rodell, Christopher B ^b   Dinh, Patrick V ^a   Hung, George ^a   Macarthur, John W ^a   Soopan, Renganaden V ^a   Burdick, Jason A ^b   Atluri, Pavan ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cellular therapy; hydrogel; ischemic myocardium; shear thinning gel

Indexed keywords

BETA CYCLODEXTRIN; CD34 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; HYALURONIC ACID; VASCULOTROPIN RECEPTOR 2; BETA CYCLODEXTRIN DERIVATIVE; GREEN FLUORESCENT PROTEIN; HYDROGEL;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MIGRATION; CELL THERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER FLOWMETRY; ECHOCARDIOGRAPHY; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; FLUORESCENCE MICROSCOPY; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HYDROGEL; IMMUNOFLUORESCENCE; IN VITRO STUDY; INJECTION; LIMIT OF QUANTITATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEAR THINNING HYDROGEL; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CHEMISTRY; CONVALESCENCE; DISEASE MODEL; DOPPLER ECHOCARDIOGRAPHY; FIBROSIS; GENETIC TRANSFECTION; GENETICS; HEART VENTRICLE PRESSURE; METABOLISM; MYOCARDIAL ISCHEMIA; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; REPORTER GENE; TIME FACTOR; TISSUE SCAFFOLD; TRANSPLANTATION; WISTAR RAT;

ANIMALS; BETA-CYCLODEXTRINS; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIAL PROGENITOR CELLS; FIBROSIS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HYALURONIC ACID; HYDROGELS; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RATS, WISTAR; RECOVERY OF FUNCTION; REGENERATION; TIME FACTORS; TISSUE SCAFFOLDS; TRANSFECTION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 84948715535     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2015.07.035     Document Type: Article

References (60)

1. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, M.J. Blaha, and et al. Heart disease and stroke statistics - 2013 update: a report from the American Heart Association Circulation 127 2013 e6 e245
2. A. Araszkiewicz, S. Grajek, M. Lesiak, M. Prech, M. Pyda, M. Janus, and et al. Effect of impaired myocardial reperfusion on left ventricular remodeling in patients with anterior wall acute myocardial infarction treated with primary coronary intervention Am J Cardiol 98 2006 725 728
3. L. Bolognese, N. Carrabba, G. Parodi, G.M. Santoro, P. Buonamici, G. Cerisano, and et al. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction Circulation 109 2004 1121 1126
4. E.J. Velazquez, K.L. Lee, M.A. Deja, A. Jain, G. Sopko, A. Marchenko, and et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
5. D.R. Davis, Y. Zhang, R.R. Smith, K. Cheng, J. Terrovitis, K. Malliaras, and et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue PLoS One 4 2009 e7195
6. N. Pavo, S. Charwat, N. Nyolczas, A. Jakab, Z. Murlasits, J. Bergler-Klein, and et al. Cell therapy for human ischemic heart diseases: critical review and summary of the clinical experiences J Mol Cell Cardiol 75 2014 12 24
7. O. Iglesias-García, B. Pelacho, and F. Prósper Induced pluripotent stem cells as a new strategy for cardiac regeneration and disease modeling J Mol Cell Cardiol 62 2013 43 50
8. G. Cao, C. Liu, Z. Wan, K. Liu, H. Sun, X. Sun, and et al. Combined hypoxia inducible factor-1α and homogeneous endothelial progenitor cell therapy attenuates shunt flow-induced pulmonary arterial hypertension in rabbits J Thorac Cardiovasc Surg 150 2015 621 632
9. V. Lambert, E. Gouadon, A. Capderou, E. Le Bret, M. Ly, S. Dinanian, and et al. Right ventricular failure secondary to chronic overload in congenital heart diseases: benefits of cell therapy using human embryonic stem cell-derived cardiac progenitors J Thorac Cardiovasc Surg 149 2015 708 715.e1
10. P. Atluri, A. Trubelja, A.S. Fairman, P. Hsiao, J.W. MacArthur, J.E. Cohen, and et al. Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct Circulation 128 2013 S95 104
11. P. Atluri, C.M. Panlilio, G.P. Liao, W. Hiesinger, D.A. Harris, R.C. McCormick, and et al. Acute myocardial rescue with endogenous endothelial progenitor cell therapy Heart Lung Circ 19 2010 644 654
12. P. Atluri, J.S. Miller, R.J. Emery, G. Hung, A. Trubelja, J.E. Cohen, and et al. Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function J Thorac Cardiovasc Surg 148 2014 1090 1097 discussion 1097-98
13. J.R. Frederick, J.R. Fitzpatrick, R.C. McCormick, D.A. Harris, A.Y. Kim, J.R. Muenzer, and et al. Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis Circulation 122 2010 S107 S117
14. P. Treskes, K. Neef, S. Perumal Srinivasan, M. Halbach, C. Stamm, D. Cowan, and et al. Preconditioning of skeletal myoblast-based engineered tissue constructs enables functional coupling to myocardium in vivo J Thorac Cardiovasc Surg 149 2015 348 356
15. N.J. Leeper, A.L. Hunter, and J.P. Cooke Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells Circulation 122 2010 517 526
16. Y. Zhang, D.A. Ingram, M.P. Murphy, M.R. Saadatzadeh, L.E. Mead, D.N. Prater, and et al. Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cells Am J Physiol Heart Circ Physiol 296 2009 H1675 H1682
17. H.F. Tse, C.W. Siu, S.G. Zhu, L. Songyan, Q.Y. Zhang, W.H. Lai, and et al. Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium Eur J Heart Fail 9 2007 747 753
18. A.Y. Sheikh, B.C. Huber, K.H. Narsinh, J.M. Spin, K. van der Bogt, P.E. de Almeida, and et al. In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium Arterioscler Thromb Vasc Biol 32 2012 92 102
19. M. Hofmann, K.C. Wollert, G.P. Meyer, A. Menke, L. Arseniev, B. Hertenstein, and et al. Monitoring of bone marrow cell homing into the infarcted human myocardium Circulation 111 2005 2198 2202
20. V. Schächinger, A. Aicher, N. Döbert, R. Rover, J. Diener, S. Fichtlscherer, and et al. Pilot trial on determinants of progenitor cell recruitment to the infarcted human myocardium Circulation 118 2008 1425 1432
21. S.-H. Li, T.Y. Lai, Z. Sun, M. Han, E. Moriyama, B. Wilson, and et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: comparing intra-aortic, intravenous, and intramyocardial delivery J Thorac Cardiovasc Surg 137 2009 1225 1233.e1
22. H. Wang, J. Zhou, Z. Liu, and C. Wang Injectable cardiac tissue engineering for the treatment of myocardial infarction J Cell Mol Med 14 2010 1044 1055
23. M.A. Laflamme, K.Y. Chen, A.V. Naumova, V. Muskheli, J.A. Fugate, S.K. Dupras, and et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat Biotechnol 25 2007 1015 1024
24. T.E. Robey, M.K. Saiget, H. Reinecke, and C.E. Murry Systems approaches to preventing transplanted cell death in cardiac repair J Mol Cell Cardiol 45 2008 567 581
25. E.T. Roche, C.L. Hastings, S.A. Lewin, D.E. Shvartsman, Y. Brudno, N.V. Vasilyev, and et al. Comparison of biomaterial delivery vehicles for improving acute retention of stem cells in the infarcted heart Biomaterials 35 2014 6850 6858
26. J.D. McCall, C.C. Lin, and K.S. Anseth Affinity peptides protect transforming growth factor beta during encapsulation in poly(ethylene glycol) hydrogels Biomacromolecules 12 2011 1051 1057
27. C.C. Lin, S.M. Sawicki, and A.T. Metters Free-radical-mediated protein inactivation and recovery during protein photoencapsulation Biomacromolecules 9 2008 75 83
28. C.G. Williams, A.N. Malik, T.K. Kim, P.N. Manson, and J.H. Elisseeff Variable cytocompatibility of six cell lines with photoinitiators used for polymerizing hydrogels and cell encapsulation Biomaterials 26 2005 1211 1218
29. S.J. Bryant, C.R. Nuttelman, and K.S. Anseth Cytocompatibility of UV and visible light photoinitiating systems on cultured NIH/3T3 fibroblasts in vitro J Biomater Sci Polym Ed 11 2000 439 457
30. C.B. Rodell, A.L. Kaminski, and J.A. Burdick Rational design of network properties in guest-host assembled and shear-thinning hyaluronic acid hydrogels Biomacromolecules 14 2013 4125 4134
31. H.D. Lu, M.B. Charati, I.L. Kim, and J.A. Burdick Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism Biomaterials 33 2012 2145 2153
32. P.Y. Dankers, E.N. van Leeuwen, G.M. van Gemert, A.J. Spiering, M.C. Harmsen, L.A. Brouwer, and et al. Chemical and biological properties of supramolecular polymer systems based on oligocaprolactones Biomaterials 27 2006 5490 5501
33. Y.H. Liu, X.P. Yang, O. Nass, H.N. Sabbah, E. Peterson, and O.A. Carretero Chronic heart failure induced by coronary artery ligation in Lewis inbred rats Am J Physiol 272 1997 H722 H727
34. P. Atluri, G.P. Liao, C.M. Panlilio, V.M. Hsu, M.J. Leskowitz, K.J. Morine, and et al. Neovasculogenic therapy with granulocyte-monocyte colony stimulating factor and stromal cell derived factor-1α augments perfusion, reverses ischemia and preserves cardiomyocyte viability in ischemic cardiomyopathy Ann Thorac Surg 81 2006 1728 1736
35. J.W. MacArthur, A. Trubelja, Y. Shudo, P. Hsiao, A.S. Fairman, E. Yang, and et al. Mathematically engineered stromal cell-derived factor-1α stem cell cytokine analog enhances mechanical properties of infarcted myocardium J Thorac Cardiovasc Surg 145 2013 278 284
36. Y.J. Woo, T.J. Grand, M.F. Berry, P. Atluri, M.A. Moise, V.M. Hsu, and et al. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy J Thorac Cardiovasc Surg 130 2005 321 329
37. C. Templin, T.F. Lüscher, and U. Landmesser Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments Int J Dev Biol 55 2011 407 417
38. J.M. Singelyn, and K.L. Christman Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices J Cardiovasc Transl Res 3 2010 478 486
39. S.R. Eckhouse, B.P. Purcell, J.R. McGarvey, D. Lobb, C.B. Logdon, H. Doviak, and et al. Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction Sci Transl Med 6 2014 223ra21
40. M. Morita, C.E. Eckert, K. Matsuzaki, M. Noma, L.P. Ryan, J.A. Burdick, and et al. Modification of infarct material properties limits adverse ventricular remodeling Ann Thorac Surg 92 2011 617 625
41. E. Tous, J.L. Ifkovits, K.J. Koomalsingh, T. Shuto, T. Soeda, N. Kondo, and et al. Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling Biomacromolecules 12 2011 4127 4135
42. H. Hamdi, A. Furuta, V. Bellamy, A. Bel, E. Puymirat, S. Peyrard, and et al. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison Ann Thorac Surg 87 2009 1196 1203
43. R.R. Smith, E. Marbán, and L. Marbán Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel Biomatter 2013 10.4161/biom.24490
44. L. Qian, W. Shim, Y. Gu, M. Shirhan, K.P. Lim, L.P. Tan, and et al. Hemodynamic contribution of stem cell scaffolding in acute injured myocardium Tissue Eng Part A 18 2012 1652 1663
45. Z. Liu, H. Wang, Y. Wang, Q. Lin, A. Yao, F. Cao, and et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment Biomaterials 33 2012 3093 3106
46. X.D. Feng, X.N. Wang, X.H. Yuan, and W. Wang Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation J Thorac Cardiovasc Surg 148 2014 939 943
47. K. Cheng, T.S. Li, K. Malliaras, D.R. Davis, Y. Zhang, and E. Marbán Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction Circ Res 106 2010 1570 1581
48. J. Terrovitis, R. Lautamäki, M. Bonios, J. Fox, J.M. Engles, J. Yu, and et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery J Am Coll Cardiol 54 2009 1619 1626
49. H.C. Quevedo, K.E. Hatzistergos, B.N. Oskouei, G.S. Feigenbaum, J.E. Rodriguez, D. Valdes, and et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity Proc Natl Acad Sci U S A 106 2009 14022 14027
50. J. Luo, M.S. Weaver, J.E. Dennis, E. Whalen, M.A. Laflamme, and M.D. Allen Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes J Thorac Cardiovasc Surg 148 2014 3180 3188.e1
51. B.P. Purcell, J.A. Elser, A. Mu, K.B. Margulies, and J.A. Burdick Synergistic effects of SDF-1alpha chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium Biomaterials 33 2012 7849 7857
52. A. Avigdor, P. Goichberg, S. Shivtiel, A. Dar, A. Peled, S. Samira, and et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow Blood 103 2004 2981 2989
53. P. Huebener, T. Abou-Khamis, P. Zymek, M. Bujak, X. Ying, K. Chatila, and et al. CD44 is critically involved in infarct healing by regulating the inflammatory and fibrotic response J Immunol 180 2008 2625 2633
54. M. Korf-Klingebiel, T. Kempf, T. Sauer, E. Brinkmann, P. Fischer, G.P. Meyer, and et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction Eur Heart J 29 2008 2851 2858
55. Q. Jiang, P. Song, E. Wang, J. Li, S. Hu, and H. Zhang Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells J Mol Cell Cardiol 56 2013 1 7
56. C.B. Rodell, J.W. MacArthur, S.M. Dorsey, R.J. Wade, L.L. Wang, Y.J. Woo, and et al. Shear-thinning supramolecular hydrogels with secondary autonomous covalent crosslinking to modulate viscoelastic properties in vivo Adv Funct Mater 25 2014 636 644
57. E.L. Pardue, S. Ibrahim, and A. Ramamurthi Role of hyaluronan in angiogenesis and its utility to angiogenic tissue engineering Organogenesis 4 2008 203 214
58. M. Gnecchi, H. He, N. Noiseux, O.D. Liang, L. Zhang, F. Morello, and et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J 20 2006 661 669
59. K.B. Schuetze, T.A. McKinsey, and C.S. Long Targeting cardiac fibroblasts to treat fibrosis of the heart: focus on HDACs J Mol Cell Cardiol 70 2014 100 107
60. K. Malliaras, and E. Marbán Cardiac cell therapy: where we've been, where we are, and where we should be headed Br Med Bull 98 2011 161 185